Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease
- 1 September 2016
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 33, 74-80
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Oxidative stress, anti‐oxidant therapies and chronic kidney diseaseNephrology, 2012
- Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 2010
- Renal function, atherothrombosis extent, and outcomes in high-risk patientsAmerican Heart Journal, 2009
- Chronic Kidney DiseaseCirculation, 2007
- Endothelial Dysfunction Contributes to Renal Function–Associated Cardiovascular Mortality in a Population with Mild Renal InsufficiencyJournal of the American Society of Nephrology, 2006
- Isoprostane formation and inhibition in atherothrombosisCurrent Opinion in Pharmacology, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Role of platelets in progressive glomerular diseasesPediatric Nephrology, 1995
- Platelets in Glomerular DiseaseAnnual Review of Medicine, 1984
- Platelet hyperaggregability and the nephrotic syndromeThrombosis Research, 1979